Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665795 | SCV000789971 | likely pathogenic | Peroxisome biogenesis disorder type 3B; Peroxisome biogenesis disorder 3A (Zellweger) | 2017-02-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002532046 | SCV003444012 | pathogenic | Peroxisome biogenesis disorder 3A (Zellweger) | 2022-08-31 | criteria provided, single submitter | clinical testing | This variant is present in population databases (no rsID available, gnomAD 0.007%). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 550907). This variant has not been reported in the literature in individuals affected with PEX12-related conditions. This sequence change creates a premature translational stop signal (p.Gln17*) in the PEX12 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX12 are known to be pathogenic (PMID: 9090384, 9632816, 21031596). |